Vertex Pharmaceuticals (VRTX)

Retained Earnings

$15.69B

Quarterly · Period ending: · USD

VRTX logo

VRTX Retained Earnings

Latest reported$15.69B
VRTX Quarterly Retained Earnings (-$6.20M → $15.69B)
High-resolution chart · PNG

VRTX retained earnings history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Retained Earnings — Quarterly (USD)
Period endingRetained Earnings (USD)
15,691,200,000
14,591,400,000
13,560,000,000
12,368,900,000
11,286,000,000
10,253,100,000
9,606,800,000
8,693,800,000
7,648,400,000
11,242,000,000
10,142,400,000
9,173,600,000
8,138,300,000
7,222,600,000
6,522,800,000
5,703,900,000
4,773,400,000
3,962,900,000
3,200,800,000
2,430,659,000
1,578,731,000
1,511,807,000
858,669,000
254,479,000
-412,955,000
-1,250,225,000
-1,852,978,000
-2,436,212,000
-2,493,730,000
-2,761,157,000
-2,989,478,000
-4,540,005,000
-4,668,751,000
-4,876,111,000
-5,119,723,000
-5,220,407,000
-5,117,455,000
-5,135,451,000
-5,373,836,000
-5,406,781,000
-5,367,940,000
-5,303,415,000
-5,261,784,000
-5,188,053,000
-5,092,904,000
-4,904,056,000
-4,705,450,000
-4,528,794,000
-4,358,734,000
-4,199,352,000
-3,966,895,000
-4,011,180,000
-3,887,048,000
-3,829,883,000
-3,521,867,000
-3,445,719,000
-3,388,176,000
-3,323,245,000
-3,414,835,000
-3,573,464,000
-3,794,574,000
-3,620,505,000
-3,444,409,000
-3,264,017,000
-3,055,060,000
-2,855,054,000
-2,689,783,000
-2,531,139,000
-2,381,574,000
-2,210,277,000
-2,047,605,000
-1,905,273,000
-1,775,229,000
-1,683,908,000
-1,587,754,000
-1,502,003,000
-1,394,970,000
-1,277,203,000
-1,196,475,000
-1,169,131,000
-1,117,329,000
-1,039,671,000
-989,584,000
-951,453,000
-871,875,000
-830,887,000
-786,167,000
-743,398,000
-704,627,000
-660,358,000
-619,920,000
-578,891,000
-492,470,000
-402,542,000
-423,153,000
-391,070,000
-357,618,000
-336,599,000
-314,532,000
-311,272,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.